OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 131 filers reported holding OREXIGEN THERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is 0.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $281,000 | +903.6% | 654,000 | +1213.7% | 0.00% | – |
| Q1 2016 | $28,000 | -99.5% | 49,784 | -98.6% | 0.00% | -100.0% |
| Q4 2015 | $5,999,000 | -27.8% | 3,487,511 | -11.5% | 0.01% | -18.8% |
| Q3 2015 | $8,313,000 | -63.8% | 3,939,973 | -15.2% | 0.02% | -62.8% |
| Q2 2015 | $22,994,000 | +17.6% | 4,645,302 | +86.0% | 0.04% | +16.2% |
| Q1 2015 | $19,557,000 | +241.3% | 2,497,696 | +164.2% | 0.04% | +208.3% |
| Q4 2014 | $5,730,000 | +84.8% | 945,530 | +88.5% | 0.01% | +50.0% |
| Q2 2014 | $3,100,000 | -79.8% | 501,675 | -78.7% | 0.01% | -82.2% |
| Q1 2014 | $15,326,000 | +2.3% | 2,357,872 | -11.4% | 0.04% | -4.3% |
| Q4 2013 | $14,986,000 | +701.4% | 2,661,908 | +772.4% | 0.05% | +683.3% |
| Q3 2013 | $1,870,000 | +1420.3% | 305,109 | +1349.3% | 0.01% | – |
| Q2 2013 | $123,000 | – | 21,052 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,250,000 | $8,125,000 | 5.71% |
| Rock Springs Capital Management LP | 830,000 | $5,395,000 | 1.24% |
| First Light Asset Management, LLC | 195,359 | $1,270,000 | 0.90% |
| Palo Alto Investors LP | 3,338,048 | $21,698,000 | 0.90% |
| Rhenman & Partners Asset Management AB | 329,199 | $2,140,000 | 0.64% |
| NEA Management Company, LLC | 1,935,300 | $12,579,000 | 0.62% |
| PFM Health Sciences, LP | 5,129,129 | $33,339,000 | 0.60% |
| Sivik Global Healthcare LLC | 124,145 | $807,000 | 0.50% |
| QVT Financial LP | 1,322,729 | $8,598,000 | 0.49% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 433,657 | $2,819,000 | 0.41% |